ConductScience.org, home

Paper · 37726886

References162

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121135505Activation of the unfolded protein response and autophagy after hepatitis C virus infection suppresses innate antiviral immunity in vitro.J Clin Invest2011https://conductscience.org/library/papers/21135505PubMed
220196837Association between C282Y and H63D mutations of the HFE gene with hepatocellular carcinoma in European populations: a meta-analysis.J Exp Clin Cancer Res2010https://conductscience.org/library/papers/20196837PubMed
332730345Increased hepatic and circulating chemokine and osteopontin expression occurs early in human NAFLD development.PLoS One2020https://conductscience.org/library/papers/32730345PubMed
433808740A PDCD1 Role in the Genetic Predisposition to NAFLD-HCC?Cancers (Basel)2021https://conductscience.org/library/papers/33808740PubMed
533748726NAFLD and MAFLD as emerging causes of HCC: A populational study.JHEP Rep2021https://conductscience.org/library/papers/33748726PubMed
634629183Chaperone-mediated autophagy and disease: Implications for cancer and neurodegeneration.Mol Aspects Med2021https://conductscience.org/library/papers/34629183PubMed
728137313The evolving concept of liver cancer stem cells.Mol Cancer2017https://conductscience.org/library/papers/28137313PubMed
836293184Cancer Stem Cells in Hepatocellular Carcinoma: Intrinsic and Extrinsic Molecular Mechanisms in Stemness Regulation.Int J Mol Sci2022https://conductscience.org/library/papers/36293184PubMed
934440803NAFLD-Related Hepatocarcinoma: The Malignant Side of Metabolic Syndrome.Cells2021https://conductscience.org/library/papers/34440803PubMed
1034329775Treatment Algorithm for Managing Chronic Hepatitis B Virus Infection in the United States: 2021 Update.Clin Gastroenterol Hepatol2022https://conductscience.org/library/papers/34329775PubMed
1134506016CK19 Predicts Recurrence and Prognosis of HBV Positive HCC.J Gastrointest Surg2022https://conductscience.org/library/papers/34506016PubMed
1223712051Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C.J Hepatol2013https://conductscience.org/library/papers/23712051PubMed
1331728429Hepatocellular carcinoma in alcoholic and non-alcoholic fatty liver disease-one of a kind or two different enemies?Transl Gastroenterol Hepatol2019https://conductscience.org/library/papers/31728429PubMed
1435938354Blockade of T-cell receptor with Ig and ITIM domains elicits potent antitumor immunity in naturally occurring HBV-related HCC in mice.Hepatology2023https://conductscience.org/library/papers/35938354PubMed
1525421688Detection of epigenetic aberrations in the development of hepatocellular carcinoma.Methods Mol Biol2015https://conductscience.org/library/papers/25421688PubMed
1622655206Hepatocellular carcinoma: focus on different aspects of management.ISRN Oncol2012https://conductscience.org/library/papers/22655206PubMed
1727006468C-terminal truncated hepatitis B virus X protein promotes hepatocellular carcinogenesis through induction of cancer and stem cell-like properties.Oncotarget2016https://conductscience.org/library/papers/27006468PubMed
1828595519T-cell-associated immunotherapy: a promising strategy for the treatment of hepatocellular carcinoma.Immunotherapy2017https://conductscience.org/library/papers/28595519PubMed
1924457013Virus associated malignancies: the role of viral hepatitis in hepatocellular carcinoma.Semin Cancer Biol2014https://conductscience.org/library/papers/24457013PubMed
2028626852Global Epidemiology of Hepatocellular Carcinoma (HCC Epidemiology).J Gastrointest Cancer2017https://conductscience.org/library/papers/28626852PubMed

papers-2026-11-12-0.1.0

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/papers/v1/37726886/references